Friday, July 10, 2026

pharma · Hepatocellular Carcinoma · Acute Lymphoblastic Leukemia

Anhui Provincial Hospital

Anhui Provincial Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hepatocellular Carcinoma, Acute Lymphoblastic Leukemia. NovaPharmaNews links 2 clinical program(s), 0 drug p

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Clinical program

Metabolically Armed CD19 CAR-T cells

Phase 1 · small molecule · Acute Lymphoblastic Leukemia

Metabolically Armed CD19 CAR-T cells for Acute Lymphoblastic Leukemia is a Phase 1 program (small_molecule) at Anhui Provincial Hospital with 1 ClinicalTrials.gov record(s).

← All Anhui Provincial Hospital projects Phase 1 small molecule active

Internal code Meta10-19-004

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Anhui Provincial Hospital
Phase
Phase 1
Modality
small_molecule
Indication
Acute Lymphoblastic Leukemia
Status
active
Trials
1